Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated
pathology, COVID-19, have been of particular concerns these last months due to the …

We conducted this systematic review and meta‐analysis to evaluate the existing evidence
and to quantitatively synthesise evidence on the impact of therapeutic plasma exchange …

Background and objectives Cytokine release syndrome in COVID‐19 is due to a
pathological inflammatory response of raised cytokines. Removal of these cytokines by …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a major
pandemic. While vaccine development moves forward, optimal treatment continues to be …

We present a case series of three patients with COVID-19 who were admitted to our
intensive care unit due to acute respiratory distress syndrome, brain infarction, pulmonary …

The appropriate immunosuppressive regimen in kidney transplant recipients with severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2/COVID-19) infection remains …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is a major public health event
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has …

AC showed progressive infiltrate and diffuse gridding shadow before the treatment of TPE,
DF showed lesions were partially absorbed after the treatment. The patient received …

Although most patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2) experience respiratory manifestations, multi-organ dysfunction is frequent. Almost 20% of …

We retrospectively analyzed the characteristics and outcomes of five patients with COVID‐
19 who were received glucocorticoid (with or without pulse therapy) and therapeutic plasma …